Teliphen Tablet (Talniflumate)

Adult dose

Administer 370 mg of talniflumate orally 3 times daily. For severe cases, administer 740 mg per dose. The dose may be adjusted according to age and symptoms.

This medication may cause gastric bleeding in individuals who regularly consume more than three servings of alcohol daily, so it should be taken only after consulting a physician or pharmacist. This medication can affect the cardiovascular system and may increase the risk of serious cardiovascular diseases, such as myocardial infarction or stroke, so individuals with cardiovascular diseases or risk factors should be cautious. Serious adverse reactions such as bleeding, ulceration, and perforation may occur in the gastrointestinal tract, particularly in the elderly, who may be at higher risk, necessitating close monitoring for gastrointestinal symptoms during treatment. Individuals with a history of peptic ulcers, allergies to this drug or its components, hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs, pregnant or breastfeeding women, and those with severe liver, kidney, or heart disorders should not take this medication. Individuals with mild to moderate liver, kidney, or heart disorders, the elderly, and those taking diuretics should use this medication cautiously. Those allergic to specific dye components should also be vigilant. During treatment, nausea, vomiting, diarrhea, abdominal pain, skin rashes, hives, and, rarely, serious skin reactions or respiratory symptoms may occur, so it is essential to consult a healthcare professional immediately if any adverse reactions arise. This medication should be used at the lowest effective dose and for the shortest duration possible, and regular blood tests and liver and kidney function tests are required for long-term use. It is advisable to avoid taking this medication with other non-steroidal anti-inflammatory drugs, and there may be interactions with specific blood pressure medications, diuretics, anticoagulants, lithium, and methotrexate, so consult healthcare professionals if co-administering. During pregnancy, especially in late stages, it may harm the fetus, so it should not be taken; if breastfeeding, it may transfer to breast milk, necessitating suspension of nursing or discontinuation of the drug. The use of this medication is not recommended for children under 12 years old, and the elderly should start with a lower dose and be vigilant for adverse reactions. This medication should be stored out of reach of children, and transferring it to other containers could compromise its quality, so caution is advised.

• Nausea
• vomiting
• phototoxicity
• asthma attacks
• systemic malaise due to hypotension
• hypersensitivity shock
• diarrhea
• abdominal distension
• constipation
• dyspepsia

This medication must be stored in a container that blocks light and is sealed to prevent air access. The storage temperature should be maintained between 1 to 30 degrees Celsius.

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle